| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 7.68e-05 | 5 | 56 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 1.40e-04 | 36 | 56 | 3 | GO:0140416 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 2.75e-04 | 9 | 56 | 2 | GO:0001181 | |
| Domain | NBPF_dom | 4.14e-06 | 11 | 56 | 3 | IPR010630 | |
| Domain | NBPF | 4.14e-06 | 11 | 56 | 3 | PS51316 | |
| Domain | DUF1220 | 4.14e-06 | 11 | 56 | 3 | PF06758 | |
| Domain | TAF_II_230-bd | 8.83e-06 | 2 | 56 | 2 | IPR009067 | |
| Domain | TFIID_sub1_DUF3591 | 8.83e-06 | 2 | 56 | 2 | IPR022591 | |
| Domain | - | 8.83e-06 | 2 | 56 | 2 | 1.10.1100.10 | |
| Domain | TBP-binding | 8.83e-06 | 2 | 56 | 2 | PF09247 | |
| Domain | DUF3591 | 8.83e-06 | 2 | 56 | 2 | PF12157 | |
| Domain | TAF1_animal | 8.83e-06 | 2 | 56 | 2 | IPR011177 | |
| Domain | - | 1.31e-04 | 6 | 56 | 2 | 2.140.10.10 | |
| Domain | Quinoprotein_ADH-like_fam | 1.31e-04 | 6 | 56 | 2 | IPR027295 | |
| Domain | DUF1220 | 3.14e-04 | 9 | 56 | 2 | SM01148 | |
| Domain | Dynein_HC_stalk | 7.85e-04 | 14 | 56 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 7.85e-04 | 14 | 56 | 2 | IPR013602 | |
| Domain | DHC_N2 | 7.85e-04 | 14 | 56 | 2 | PF08393 | |
| Domain | MT | 7.85e-04 | 14 | 56 | 2 | PF12777 | |
| Domain | DHC_fam | 9.04e-04 | 15 | 56 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 9.04e-04 | 15 | 56 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 9.04e-04 | 15 | 56 | 2 | PF03028 | |
| Domain | Bromodomain_CS | 2.74e-03 | 26 | 56 | 2 | IPR018359 | |
| Domain | Abhydrolase_1 | 3.88e-03 | 31 | 56 | 2 | PF00561 | |
| Domain | AB_hydrolase_1 | 4.39e-03 | 33 | 56 | 2 | IPR000073 | |
| Domain | BROMODOMAIN_1 | 5.50e-03 | 37 | 56 | 2 | PS00633 | |
| Domain | Bromodomain | 5.79e-03 | 38 | 56 | 2 | PF00439 | |
| Domain | - | 6.67e-03 | 746 | 56 | 7 | 3.40.50.300 | |
| Domain | BROMODOMAIN_2 | 6.72e-03 | 41 | 56 | 2 | PS50014 | |
| Domain | BROMO | 7.04e-03 | 42 | 56 | 2 | SM00297 | |
| Domain | Bromodomain | 7.04e-03 | 42 | 56 | 2 | IPR001487 | |
| Domain | - | 7.04e-03 | 42 | 56 | 2 | 1.20.920.10 | |
| Domain | Neurotransmitter_ion_chnl_CS | 8.05e-03 | 45 | 56 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 8.40e-03 | 46 | 56 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 8.75e-03 | 47 | 56 | 2 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 8.75e-03 | 47 | 56 | 2 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 8.75e-03 | 47 | 56 | 2 | IPR006029 | |
| Domain | - | 8.75e-03 | 47 | 56 | 2 | 2.70.170.10 | |
| Domain | Neur_channel | 8.75e-03 | 47 | 56 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 8.75e-03 | 47 | 56 | 2 | IPR006202 | |
| Domain | Quinoprotein_ADH-like_supfam | 1.10e-02 | 53 | 56 | 2 | IPR011047 | |
| Pubmed | 4.60e-15 | 21 | 62 | 7 | 16079250 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 1.91e-09 | 10 | 62 | 4 | 22973535 | |
| Pubmed | NBPF8 DOCK5 NBPF12 ABCA12 NBPF9 NBPF10 NBPF11 TECTA NBPF14 EIF2AK3 | 2.42e-08 | 513 | 62 | 10 | 25798074 | |
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 19959467 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 6.12e-07 | 170 | 62 | 6 | 23314748 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 38804708 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 10070062 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 22842574 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 11352564 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 27571988 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 34403156 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 20214815 | ||
| Pubmed | TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. | 9.37e-06 | 3 | 62 | 2 | 11592977 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 16822332 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 12217962 | ||
| Pubmed | TAF7: a possible transcription initiation check-point regulator. | 9.37e-06 | 3 | 62 | 2 | 16407123 | |
| Pubmed | Two new mutations in linkage group XVI of the house mouse. Flaky tail and varitint-waddler-J. | 4.67e-05 | 6 | 62 | 2 | 4557539 | |
| Pubmed | Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. | 8.69e-05 | 8 | 62 | 2 | 2034279 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 10331952 | ||
| Pubmed | Genetic mapping in the region of the mouse X-inactivation center. | 8.69e-05 | 8 | 62 | 2 | 1974879 | |
| Pubmed | Deletion of Prl7d1 causes placental defects at mid-pregnancy in mice. | 8.69e-05 | 8 | 62 | 2 | 31012985 | |
| Pubmed | Physical mapping of 2000 kb of the mouse X chromosome in the vicinity of the Xist locus. | 8.69e-05 | 8 | 62 | 2 | 8468051 | |
| Pubmed | High-density molecular map of the central span of the mouse X chromosome. | 8.69e-05 | 8 | 62 | 2 | 1675191 | |
| Pubmed | Cloning and characterization of a new human Xq13 gene, encoding a putative helicase. | 1.12e-04 | 9 | 62 | 2 | 7874112 | |
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 12665565 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 9751712 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 23457482 | ||
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 2055107 | ||
| Pubmed | Characterization of a murine gene expressed from the inactive X chromosome. | 1.70e-04 | 11 | 62 | 2 | 2034278 | |
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 7805729 | ||
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 8012115 | ||
| Pubmed | Requirement of tissue-selective TBP-associated factor TAFII105 in ovarian development. | 2.41e-04 | 13 | 62 | 2 | 11557891 | |
| Pubmed | Rps4 maps near the inactivation center on the mouse X chromosome. | 2.41e-04 | 13 | 62 | 2 | 1740345 | |
| Pubmed | XIST and the mapping of the X chromosome inactivation centre. | 2.41e-04 | 13 | 62 | 2 | 1772416 | |
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 489953 | ||
| Pubmed | 2.69e-04 | 174 | 62 | 4 | 35031058 | ||
| Pubmed | TGF-β specifies TFH versus TH17 cell fates in murine CD4+ T cells through c-Maf. | 2.81e-04 | 14 | 62 | 2 | 38427718 | |
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 14580349 | ||
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 20171287 | ||
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 30237242 | ||
| Pubmed | 3.83e-04 | 191 | 62 | 4 | 24146773 | ||
| Pubmed | Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis. | 4.18e-04 | 17 | 62 | 2 | 24737748 | |
| Pubmed | Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain. | 4.70e-04 | 18 | 62 | 2 | 31910261 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 5.73e-04 | 807 | 62 | 7 | 22681889 | |
| Pubmed | 6.30e-04 | 218 | 62 | 4 | 19460752 | ||
| Pubmed | 7.72e-04 | 23 | 62 | 2 | 23725790 | ||
| Pubmed | Synergistic integration of Netrin and ephrin axon guidance signals by spinal motor neurons. | 8.41e-04 | 24 | 62 | 2 | 26633881 | |
| Pubmed | 1.06e-03 | 251 | 62 | 4 | 29031500 | ||
| Pubmed | 1.07e-03 | 27 | 62 | 2 | 34709416 | ||
| Pubmed | 1.07e-03 | 27 | 62 | 2 | 25133637 | ||
| Pubmed | NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. | 1.07e-03 | 27 | 62 | 2 | 23359859 | |
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 1.23e-03 | 29 | 62 | 2 | 31491374 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 1.28e-03 | 1201 | 62 | 8 | 35696571 | |
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 1.32e-03 | 30 | 62 | 2 | 15782174 | |
| Pubmed | Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. | 1.41e-03 | 31 | 62 | 2 | 25838543 | |
| Pubmed | 1.50e-03 | 32 | 62 | 2 | 14973295 | ||
| Pubmed | Reevaluating human gene annotation: a second-generation analysis of chromosome 22. | 1.59e-03 | 33 | 62 | 2 | 12529303 | |
| Pubmed | 1.59e-03 | 33 | 62 | 2 | 18199763 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 1.70e-03 | 974 | 62 | 7 | 28675297 | |
| Interaction | NEK4 interactions | NBPF8 DOCK5 NBPF12 ABCA12 NBPF9 NBPF10 NBPF11 TECTA NBPF14 EIF2AK3 | 8.95e-06 | 582 | 61 | 10 | int:NEK4 |
| Cytoband | 1q21.1 | 2.32e-08 | 62 | 62 | 5 | 1q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 1.81e-05 | 404 | 62 | 6 | chr1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p11 | 3.71e-04 | 21 | 62 | 2 | chr1p11 | |
| Cytoband | 3q27.1 | 6.16e-04 | 27 | 62 | 2 | 3q27.1 | |
| GeneFamily | Neuroblastoma breakpoint family | 5.14e-17 | 23 | 36 | 8 | 662 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 3.16e-03 | 42 | 36 | 2 | 602 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 3.16e-06 | 320 | 60 | 8 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.55e-06 | 175 | 62 | 5 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 5.50e-06 | 182 | 62 | 5 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.50e-06 | 182 | 62 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.96e-06 | 185 | 62 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.28e-06 | 187 | 62 | 5 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.44e-06 | 188 | 62 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-06 | 190 | 62 | 5 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-06 | 190 | 62 | 5 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.50e-06 | 194 | 62 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 7.69e-06 | 195 | 62 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.70e-06 | 200 | 62 | 5 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | Control-B_activate-7|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.26e-05 | 130 | 62 | 4 | d3343c19d61928f18e7d707eda5dec6e0fd2a9a2 | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 6.00e-05 | 152 | 62 | 4 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | COVID-CD4-antiviral_CD4|COVID / Condition, Cell_class and T cell subcluster | 6.47e-05 | 155 | 62 | 4 | 7e5ae034036fe85915d38a24195501e6d3bcbfb0 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 8.64e-05 | 167 | 62 | 4 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.90e-05 | 173 | 62 | 4 | 03b50b2376d353748a32bf14a9fc8341ea61dbca | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.90e-05 | 173 | 62 | 4 | 12da47b90aecedaa31764ff7ddb853ee39123e9d | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.90e-05 | 173 | 62 | 4 | 2978c744d3c8dcaa2b9bb225abf846f82e8f9176 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.90e-05 | 173 | 62 | 4 | 85083b9ce20351dd69aa2327ad087b848b4307ff | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.90e-05 | 173 | 62 | 4 | 23d4a315a0ad5c6fc77bcfc18b6c1ff55be99e8f | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.08e-04 | 177 | 62 | 4 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-04 | 178 | 62 | 4 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | COVID-19_Convalescent|World / Disease condition and Cell class | 1.18e-04 | 181 | 62 | 4 | a62115a8da486fc61225901c72b1ec70bcaf4c36 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 1.20e-04 | 182 | 62 | 4 | a5fd392178c2f533e265d2e3ce63b90c2553e4c1 | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.20e-04 | 182 | 62 | 4 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 182 | 62 | 4 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 183 | 62 | 4 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 183 | 62 | 4 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.23e-04 | 183 | 62 | 4 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | B_cells-ABCs|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.23e-04 | 183 | 62 | 4 | bf9c6fe3ce4e44e4056027257eab8448c39c4fb8 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 184 | 62 | 4 | 4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 186 | 62 | 4 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | mild-unassigned|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.31e-04 | 186 | 62 | 4 | 5b2e1a58916f392fa1156bf9210df528775248ff | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 186 | 62 | 4 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-04 | 186 | 62 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.34e-04 | 187 | 62 | 4 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 187 | 62 | 4 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 187 | 62 | 4 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-04 | 188 | 62 | 4 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-04 | 189 | 62 | 4 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.42e-04 | 190 | 62 | 4 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.45e-04 | 191 | 62 | 4 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.48e-04 | 192 | 62 | 4 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.48e-04 | 192 | 62 | 4 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.48e-04 | 192 | 62 | 4 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 1.48e-04 | 192 | 62 | 4 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 192 | 62 | 4 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-04 | 193 | 62 | 4 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-04 | 193 | 62 | 4 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.51e-04 | 193 | 62 | 4 | 22455801194bd8c73c5c397f5eac4f723429c383 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 194 | 62 | 4 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.54e-04 | 194 | 62 | 4 | e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 194 | 62 | 4 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.57e-04 | 195 | 62 | 4 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.57e-04 | 195 | 62 | 4 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 1.60e-04 | 196 | 62 | 4 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 197 | 62 | 4 | 5fbbc570a4e77c703f569a4f85ce2d8af67d6297 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 197 | 62 | 4 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | normal_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.63e-04 | 197 | 62 | 4 | c838d0f64e3b43a616a9e381b8139bfe9aa32da7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 198 | 62 | 4 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 199 | 62 | 4 | 2aed8f4a225a3762a5e7ce99aacad9b2a37d61f1 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 199 | 62 | 4 | c40ca26345753a2197bd9389d7323f7491c1e11d | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | 76e90231aa94afc12e618da8ae314c51644acab4 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.73e-04 | 200 | 62 | 4 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | e3e80cb16e0d2e24efc16b62316a6da91bf81ea5 | |
| Drug | Pesticides | 1.35e-07 | 150 | 60 | 7 | ctd:D010575 | |
| Disease | serum gamma-glutamyl transferase measurement | 3.13e-04 | 914 | 56 | 8 | EFO_0004532 | |
| Disease | Child Behaviour Checklist assessment | 5.31e-04 | 18 | 56 | 2 | EFO_0005661 | |
| Disease | pseudotumor cerebri | 1.12e-03 | 26 | 56 | 2 | EFO_1001132 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 1.38e-03 | 115 | 56 | 3 | EFO_0007878, EFO_0010724 | |
| Disease | glutamate measurement | 1.39e-03 | 29 | 56 | 2 | EFO_0010487 | |
| Disease | HbA1c measurement | 1.72e-03 | 675 | 56 | 6 | EFO_0004541 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YRGQLYLQSSVRISE | 391 | Q9NZJ5 | |
| GNLYDQIVFYVAIRR | 231 | A5X5Y0 | |
| IYGRAFIYLQDSIER | 1016 | Q86UK0 | |
| TLTREQARLGYYQFQ | 3356 | Q96M86 | |
| FGFDLLVTYTNRYII | 416 | Q96IK5 | |
| FTYIRYIQQGLVRQD | 341 | Q8TBN0 | |
| QTITKQYYRRAQGIF | 71 | P59190 | |
| LVRAYGNIERCFLVY | 161 | Q9HCJ3 | |
| YITTVIQRIFYAVNR | 261 | Q9Y5P8 | |
| YYATVTLDQVRNILR | 121 | Q5T6V5 | |
| SYIFRQLVSAVGYLR | 1106 | Q96RG2 | |
| VFTVEQQRILQRYYE | 6 | Q7Z353 | |
| RRAYGTNYIETLRVQ | 141 | Q9Y6A4 | |
| AVIYGLLNENFRREY | 291 | Q13585 | |
| IQRTFTDIGIKYYRN | 141 | Q86YR7 | |
| YVYIFSAVLRISQRQ | 216 | Q8NGZ2 | |
| IAGYQIFQITLTRSY | 2836 | Q96JB1 | |
| VYRGRIAVFSVSVFY | 841 | Q9P265 | |
| VTAYFRGVQARVIYQ | 321 | Q96A46 | |
| GYYTCVEVIFTLRRQ | 251 | P48167 | |
| RQYVYGVLFSLAESR | 606 | Q9NZB2 | |
| QVETYLRSEGVLVRY | 2386 | Q9Y4D8 | |
| YRRYFTQIVGFFVVE | 331 | Q8TAG9 | |
| RNRTFDTYIGQGYVI | 301 | O95302 | |
| RLSPYVNYQFRVIAI | 691 | O94856 | |
| FRVQYYVENGRLISD | 111 | Q96NE9 | |
| IIRRAFYSLGNYIVA | 301 | Q5EBM0 | |
| VQNGFIRNYTIFYRT | 546 | P40189 | |
| IRNYTIFYRTIIGNE | 551 | P40189 | |
| DIFYILNGNIRDRYQ | 266 | Q8TCB0 | |
| FIIQSRVLYLRFYGQ | 766 | Q9H7D0 | |
| VLYETRARYFLVGSN | 16 | Q92562 | |
| VGREFVRQYYTLLNQ | 11 | Q13283 | |
| YFRLNTLASLGYVVV | 686 | Q6V1X1 | |
| YSRVGRSVTDVYLLN | 66 | P25024 | |
| YSNGIRTEQDFYVRL | 116 | Q9UH73 | |
| AGQLVTEIRQYFYRN | 656 | Q9Y2E5 | |
| QTYTINLYLVETGRR | 371 | Q8N766 | |
| EVGRFGQLTYVRSYQ | 361 | Q96RP9 | |
| YYLQTFVSEIRRVVA | 81 | Q9H4I8 | |
| YLITQRITYEQGVRA | 486 | P51513 | |
| SFLTYLQQEIFRYIR | 961 | Q5HYA8 | |
| YYLQTFVSEIRRVVA | 81 | Q9NQF3 | |
| SVVYRFFTRLGQIYQ | 16 | O15258 | |
| FQYRLVEYTRADGTV | 306 | Q8TAD8 | |
| YRSAFYILEQQRVGL | 621 | Q3BBV2 | |
| YRSAFYVLEQQRVGL | 656 | P0DPF3 | |
| YRSAFYILEQQRVGL | 656 | Q6P3W6 | |
| YRSAFYVLEQQRIGL | 656 | Q86T75 | |
| YRSAFYVLEQQRVGL | 1171 | Q5TAG4 | |
| YRSAFYVLEQQRVGL | 316 | Q5TI25 | |
| YRSAFYVLEQQRIGL | 41 | P0DPF2 | |
| YRSAFYVLEQQRVGL | 1261 | P0DPF2 | |
| YRSAFYVLEQQRVGL | 2481 | P0DPF2 | |
| YRSAFYVLEQQRVGL | 3701 | P0DPF2 | |
| YRSAFYVLEQQRVGL | 4921 | P0DPF2 | |
| YRSAFYVLEQQRVGL | 316 | B4DH59 | |
| YRSAFYILEQQRVGL | 391 | B4DH59 | |
| YRSAFYILEQQRVGL | 466 | B4DH59 | |
| YRSAFYILEQQRVGL | 541 | B4DH59 | |
| YRSAFYILEQQRVGL | 616 | B4DH59 | |
| TRQGYYIRELVDIFV | 786 | Q8IZX4 | |
| RTRQGYYIRELVDIF | 766 | P21675 | |
| LRYFSLYEVALVTQG | 731 | Q9Y6C5 | |
| TYSGVFRTQRVDLYQ | 2096 | P48634 | |
| SVIIIFYCYRVNRQQ | 181 | P37173 | |
| YIGTTIVVRQVGRYL | 276 | Q96B86 | |
| YRQGEVVLTTRDVLY | 1946 | O75443 | |
| QIIYGARGTRYQTFV | 326 | Q9C035 | |
| RRYVAQSVQLFILYF | 281 | Q9BSE2 | |
| VARQTLETIRSVGYY | 1961 | Q6N022 | |
| LVIGVTLYRRSQSDY | 396 | Q6UXZ4 |